NCT05482464View on ClinicalTrials.gov

Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Inflammatory Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Casein glycomacropeptide (CGMP)

Casein glycomacropeptide (CGMP) supplementation for 3 weeks

Trial Locations (1)

97331

Milam Hall, Room 001, Corvallis

All Listed Sponsors
collaborator

BUILD Dairy

UNKNOWN

collaborator

Agropur

UNKNOWN

lead

Oregon State University

OTHER

NCT05482464 - Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter